Hypothalamus and Pituitary BSC
Objectives
Review case presentations related to ADH (antidiuretic hormone).
Correlate signs and symptoms of hypopituitarism to deficiencies in pituitary hormones.
Evaluate the causes of hyperprolactinemia.
Correlate the metabolic functions of GH (growth hormone) to the clinical features of acromegaly.
Differentiate between the actions of GH and IGF-I (insulin-like growth factor I) in acromegaly. Apply the characteristics of disease presentation to either GH or IGF-I effects.
Describe appropriate screening tests, as well as identify the appropriate suppression or stimulatory tests for endocrine disorders (based on the physiology of feedback loops).
Physiology Knowledge Check
Damage to the pituitary stalk may result in an increase in:
A. FSH (Follicle-stimulating hormone)
B. GH (Growth Hormone)
C. ACTH (Adrenocorticotropic hormone)
D. PRL (Prolactin)
E. TSH (Thyroid-stimulating hormone)
During a fast, GH secretion is stimulated by:
F. Insulin
G. Glucagon
H. Ghrelin
I. Somatostatin
J. GnRH (Gonadotropin-releasing hormone)
The pituitary cell that produces two hormones is:
K. Thyrotrope
L. Gonadotrope
M. Corticotrope
N. Somatotrope
A 74-year-old patient presents with headaches, difficulty concentrating, impaired memory, muscle cramps, and weakness. Laboratory values report serum sodium of 120 mmol/L. Which would be compatible with a differential diagnosis of syndrome of inappropriate ADH secretion?
O. Low plasma AVP (Arginine vasopressin) levels
P. Serum osmolarity of 265 mOsm/L
Q. Plasma glucose 300 mg/dL
R. Urinary osmolarity <400 mOsm/L
Posterior Pituitary Clinical Correlations #1
A 32-year-old patient post-concussion showed increased urine output with low urine osmolality 24 hours later.
Diagnosis and hormone responsible:
Likely diagnosis: Diabetes insipidus.
Hormone responsible: ADH deficiency.
Posterior Pituitary Clinical Correlations #2
A 56-year-old man with lung cancer and a grand mal seizure has:
Serum [Na + ]: 110 mEq/L (normal 140)
Urine Osmolarity: 650 mOsm/L (concentrated)
Diagnosis: Likely SIADH (Syndrome of Inappropriate Antidiuretic Hormone secretion).
Treatment: Intravenous infusion of hypertonic NaCl and demeclocycline (ADH antagonist).
Posterior Pituitary Clinical Correlations #3
A 27-year-old female developed hypernatremia and increased dilute urine output after head trauma.
ADH levels: Decreased.
Effects of decreased ADH levels: Increased serum osmolarity, decreased urine osmolarity.
Case #1: Mrs. Omaya
Chief Complaint: Extreme fatigue since childbirth 9 months ago.
Patient Profile: 25-year-old female, previous good health, problematic lactation post-delivery, amenorrhea, weight retention, changes in skin and voice, history of postpartum hemorrhage requiring transfusion.
Vital Signs: T 37°C, BP 100/70 mmHg, P 60/min.
Physical Exam: Coarse skin texture, otherwise normal.
Mrs. Omaya’s Symptoms/History
Fatigue
Unable to lactate
Amenorrhea
Weight retention
Changes in skin and voice post-pregnancy
History: Normal pregnancy, postpartum hemorrhage.
Mrs. Omaya’s Laboratory Values
Plasma Concentration | Value | Normal Range |
|---|---|---|
Sodium | 130 mmol/L | 137-147 |
Potassium | 4.5 mmol/L | 3.5-5.3 |
Chloride | 102 mmol/L | 99-108 |
CO2 | 25 mmol/L | 22-28 |
Glucose (fasting) | 62 mg/dL | 60-109 |
Cortisol (8 AM) | 3.0 µg/dL | 5-25 |
Free T4 | 0.4 µg/dL | 0.6-1.7 |
IGF-1 | 64 ng/mL | 90-360 |
TSH | 0.1 µU/ml | 0.5-5 |
Prolactin | 3.6 ng/mL | 5-25 |
LH | 2.8 mU/mL | 5-30 |
FSH | 2.3 mU/mL | 5-16 |
Growth Hormone (GH) | < 0.25 ng/mL | 0-10 |
Sheehan Syndrome
Correlating Mrs. Omaya’s symptoms:
Inability to lactate → indicate prolactin deficiency.
Amenorrhea → due to insufficient LH and FSH.
Weight retention/skin changes → suggest cortisol deficiency.
Fatigue → linked to low thyroid hormones.
Susceptibility of Pregnant Women to Pituitary Infarction: Increased blood supply during pregnancy can make pituitary tissue vulnerable.
Posterior Pituitary Affected: Damage may not be uniform across pituitary; often anterior lobe is significantly affected.
Prolactin Regulation and Stimulation
Hypothalamus: Prolactin induces dopamine synthesis.
Dopamine: Main inhibitory factor limiting prolactin production.
Thyrotropin-releasing hormone (TRH) stimulates prolactin release.
Stimulatory Factors
Pregnancy (induced by estrogen)
Breast-feeding
Sleep
Stress
TRH
Inhibitory Factors
Dopamine
Dopamine antagonists (such as bromocriptine)
Somatostatin
Prolactin (negative feedback)
Causes of Hyperprolactinemia
Physiologic Causes:
Pregnancy
Nipple stimulation
Stress
Pathologic Causes:
Lactotroph adenomas
Decreased dopaminergic inhibition due to hypothalamic or pituitary diseases.
Drug use (e.g., antipsychotics).
Other Causes:
Estrogen
Hypothyroidism
Chest wall injury
Chronic renal failure
Idiopathic hyperprolactinemia
Macroprolactinemia
Genetic causes.
Serum Prolactin Levels in Pregnancy and Breastfeeding
During pregnancy, increased levels of prolactin serve to suppress GnRH.
Serum prolactin levels change based on:
Pregnancy duration (higher in later months).
Lactation status postpartum.
Case #2: Eloise
Chief Complaint: Amenorrhea for 3 months post-motorcycle accident.
Patient Profile: 28-year-old female, has gained weight, drinks and urinates more than prior to the accident, reports galactorrhea.
Vital Signs: T 36.5°C, P 84/min, BP 95/60, BMI 29.
Eloise’s Laboratory Values
Test | Value | Normal Range |
|---|---|---|
Pregnancy test | Negative | |
FSH | 2 mIU/ml | 4-30 |
LH | 2 mIU/ml | 5-30 |
Cortisol (8 AM) | 2 mg/dL | 5-25 |
TSH | 0.2 mU/L | 0.5-5 |
Thyroxine (T4) | 3 mg/dL | 5-12 |
Triiodothyronine (T3) | 80 ng/dL | 115-190 |
Prolactin | 70 ng/mL | <20 |
Identifying the Cause of Hyperprolactinemia
Likely condition based on history and symptoms:
Ischemic necrosis of the pituitary.
Traumatic damage to the pituitary stalk.
Prolactinoma (adenoma of lactotropes).
Increased prolactin due to dopamine antagonist use.
Hypothyroidism.
Case #3: Megan
Chief Complaint: Irregular menses and missed periods.
Patient Profile: 30-year-old female not on hormonal contraception, normal onset of menstruation.
Physical Exam: Normal pelvic exam.
Megan’s Laboratory Values
Test | Value | Normal Range |
|---|---|---|
Pregnancy test | Negative | |
FSH | 2 mIU/ml | 4-30 |
LH | 2 mIU/ml | 5-30 |
Cortisol (4 PM) | 7 mg/dL | 3-15 |
TSH | 3.0 mU/L | 0.5-5 |
Thyroxine (T4) | 7 mg/dL | 5-12 |
Triiodothyronine (T3) | 150 ng/dL | 115-190 |
Prolactin | 220 ng/mL | 5-25 |
Identifying Causes of Megan’s Hyperprolactinemia
Likely causes:
Ischemic necrosis of the pituitary.
Hypopituitarism due to damage to the pituitary stalk.
Prolactinoma (adenoma of lactotropes).
Increased prolactin due to a dopamine antagonist.
Hypothyroidism.
Identifying the Cause of Low Gonadotropin Levels in Megan
Causes of low LH and FSH:
Negative feedback due to high prolactin levels.
Negative feedback due to stress.
Loss of LH and FSH production due to lactotroph hyperplasia.
Negative feedback from elevated estrogen levels.
PRL Suppression of LH and FSH
Illustration of hormone dynamics:
Normal hormone profiles show suppression of LH and FSH by elevated prolactin levels.
Growth Hormone
Physiologic Role of GH varies with age; typically decreases with increasing age.
Correlation Between GH Levels and Age
GH secretion patterns demonstrate a peak during ages 3-5 years, tapering off in adulthood,
The clinical significance of GH levels includes growth velocity in children and impacts on metabolism in adults.
Clinical Cases of Acromegaly
34-year-old Man: Increased shoe size, altered facial features, high IGF-1 and GH levels leading to a diagnosis of acromegaly.
42-year-old Jeweler: Noted physical changes and bitemporal hemianopsia, MRI revealed macroadenoma with elevated GH levels.
Sam Atotrope - Findings
Fasting GH level: 56 ng/ml (normal: 0-5 ng/ml).
IGF-1: 988 ng/ml (normal: 90-360 ng/ml).
Glucose suppression test showed slow suppression (persisted elevated levels).
Metabolic Dysregulation in Acromegaly
Considerations for metabolic effects of excess GH:
Changes in fat, protein, and glucose metabolism correlate with the clinical features of acromegaly (visual changes, fatigue, increased appetite).
Treatment of Acromegaly
Treatment strategies include:
Surgical resection of the pituitary tumor.
Stereotactic radiotherapy.
Medical therapy with somatostatin analogues (e.g. octreotide) or GH receptor antagonists.
Note that while some symptoms may improve, skeletal changes are typically irreversible.
Diagnosis of Acromegaly
Biochemical confirmation by measuring IGF-I levels.
Oral glucose tolerance test for GH measurement indicating insufficient suppression.
Follow-up with pituitary MRI.